Correlation Between Enliven Therapeutics and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and SAB Biotherapeutics, you can compare the effects of market volatilities on Enliven Therapeutics and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and SAB Biotherapeutics.
Diversification Opportunities for Enliven Therapeutics and SAB Biotherapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Enliven and SAB is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and SAB Biotherapeutics
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 1.51 times less return on investment than SAB Biotherapeutics. But when comparing it to its historical volatility, Enliven Therapeutics is 2.78 times less risky than SAB Biotherapeutics. It trades about 0.07 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 293.00 in SAB Biotherapeutics on September 2, 2024 and sell it today you would lose (1.00) from holding SAB Biotherapeutics or give up 0.34% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Enliven Therapeutics vs. SAB Biotherapeutics
Performance |
Timeline |
Enliven Therapeutics |
SAB Biotherapeutics |
Enliven Therapeutics and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enliven Therapeutics and SAB Biotherapeutics
The main advantage of trading using opposite Enliven Therapeutics and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.Enliven Therapeutics vs. Crinetics Pharmaceuticals | Enliven Therapeutics vs. Enanta Pharmaceuticals | Enliven Therapeutics vs. Amicus Therapeutics | Enliven Therapeutics vs. Connect Biopharma Holdings |
SAB Biotherapeutics vs. Tff Pharmaceuticals | SAB Biotherapeutics vs. Eliem Therapeutics | SAB Biotherapeutics vs. Inhibrx | SAB Biotherapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |